Cerevel Therapeutics Holdings, Inc. CERE
44.96 +44.96
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 5.63M | 4.90M | 2.73M | 397.00K | 177.00K | |
| 548.62M | 623.19M | 423.60M | 440.83M | 60.06M | |
| 280.04M | -58.83M | -190.60M | 304.14M | -11.76M | |
| -3.81M | -3.95M | -10.50M | -18.89M | -1.10M | |
| 517.50M | 251.31M | 337.10M | 442.62M | 60.06M | |
| 31.25M | 372.27M | 31.25M | 0 | 0 | |
| 73.72M | -388.83M | -435.66M | -18.89M | -1.10M | |
| 77.53M | -384.88M | -425.16M | 0 | 0 | |
| -342.30M | -293.19M | -178.55M | -117.80M | -70.72M | |
| 69.41M | 38.78M | 23.94M | 10.52M | 8.31M |